Stocks · News reference
Transcript: Lineage Cell Therapeutics Q2 2026 Earnings Conference Call
On Thursday, Lineage Cell Therapeutics (AMEX:LCTX) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Lineage Cell Therapeutics, Inc. (LCTX)
Filed: 2026-08-06 AccNo: 0001193125-26-338020 Size: 793 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Lineage Cell Therapeutics Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $1.069M Miss $1.531M Estimate